Actinium Pharmaceuticals, Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
    • Radiopharmaceuticals, Contrast Agents

Other Names/Subsidiaries

  • Cactus Ventures
See more in Biomedtracker

Latest on Actinium Pharmaceuticals, Inc.

Scrip

ITM Plots Logistics In GEP-NETs Ahead Of Drug Filing After Phase III Success

 
• By Alaric DeArment

ITM Isotope Technologies Munich is preparing the complex logistics and manufacturing it will need for commercial launch of ITM-11 (non-carrier-added 177 Lu-edotreotide), its radiopharmaceutical candid

In Vivo

Will Actinium Be Big Pharma’s Next Radiopharmaceuticals Acquisition?

 
• By David Wild

It has felt lately that there may be not be enough radiopharmaceutical companies to satisfy big pharma’s appetite. First, in December 2023, Eli Lilly and Company purchased POINT Biopharma Global In

Scrip

Novartis Looks To Maintain A Lead In Radiopharmaceuticals With Mariana Takeout

 
• By Joseph Haas

Looking to stay ahead of the competition in the fast-moving radiopharmaceutical space, Novartis AG agreed to pay $1bn up front on 2 May to acquire privately held Mariana Oncology , a deal the pharm

Scrip

AstraZeneca Pays $2bn To Keep Up With The Joneses

 
• By Elizabeth Cairns

AstraZeneca PLC first involved itself with Fusion Pharmaceuticals Inc. in 2020, striking a deal to develop novel alpha emitters. Now the UK giant has made a more definitive move, paying $2bn upfron